Savior LLC’s AbbVie ABBV Stock Holding History

Savior LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$31.9K	–	127
2023 Q1	$31.9K	Hold	200	–	–	0.03%	62
2022 Q4	$32.3K	Hold	200	–	–	0.03%	64
2022 Q3	$27K	Hold	200	–	–	0.03%	78
2022 Q2	$31K	Hold	200	–	–	0.03%	61
2022 Q1	$33K	Sell	200 -74	-27%	-$10.7K	0.02%	71
2021 Q4	$37K	Buy	274 +41	+18%	+$4.84K	﹤0.01%	72
2021 Q3	$25K	Sell	233 -270	-54%	-$30.9K	0.03%	78
2021 Q2	$57K	Hold	503	–	–	0.05%	131
2021 Q1	$54K	Hold	503	–	–	0.05%	136
2020 Q4	$54K	Buy	503 +1	+0.2%	+$96	0.04%	136
2020 Q3	$44K	Hold	502	–	–	0.05%	143
2020 Q2	$49K	Sell	502 -100	-17%	-$8.8K	0.06%	122
2020 Q1	$46K	Buy	602 +4	+0.7%	+$341	0.05%	121
2019 Q4	$53K	Buy	+598	New	+$49.6K	0.07%	142

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Savior LLC's ABBV Position: Q2 2023 in Review

Savior LLC sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 200 shares — an estimated $31.9K sold.

Savior LLC first reported a position in ABBV in Q4 2019 and held it in 14 quarters. The position peaked at $57K in Q2 2021. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Savior LLC reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Savior LLC sold 200 AbbVie shares in Q2 2023, an estimated $31.9K.
Savior LLC first reported a position in AbbVie in Q4 2019 and held it in 14 quarters.
Savior LLC's AbbVie position peaked at $57K in Q2 2021.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Savior LLC's 13F filing for Q2 2023, filed 7 Jul 2023.